NeuroMetrix Gains National TV Exposure for Quell™ Wearable Technology on ABC's Good Morning America

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), reported that Quell was featured on ABC's Good Morning America on September 17 in a segment titled "Erase Your Pain". Good Morning America is the #1 morning show in the US, reaching nearly 5 million households each week. In the segment, Quell user and Physical Therapist Valerie Gregory shared how the device has eased her osteoarthritis pain. Quell is a new, innovative, over-the-counter wearable pain relief device that utilizes patented OptiTherapy technology to provide widespread pain relief.

In addition to last week's appearance on Good Morning America, Quell has been featured in a number of other influential articles, reports, blogs, and interviews. Highlights include:

• Quell has been featured in local broadcast news in 17 markets such as the WCIU (NBC) Chicago segment titled "Quell Device for Chronic Pain". Additional segments aired in Atlanta (NBC), Washington DC (ABC), Las Vegas (ABC) and Portland (Fox).
• CEO, Shai N. Gozani, M.D., Ph.D., was interviewed by Medscape at the PAINWeek Scientific Sessions, "Wearable Nerve Stimulator Improves Chronic Pain".
• New clinical evidence that 81% of Quell users reported improvement in chronic pain and overall health was featured in several outlets including The Boston Globe "Research Says Quell Zaps Pain".
• Potential future indications for the device were picked up by Sleep Review, "In RLS Patients, NeuroMetrix Reports Positive Pilot Data for its Wearable Pain Relief Technology".
• Quell debuted on QVC on September 2, where the product was the featured innovation in the afternoon broadcast.

"We are encouraged by the increase in national and broadcast coverage over the last several weeks," said Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer of NeuroMetrix. "Quell directly addresses the chronic pain struggles of millions of Americans and we look forward to expanding awareness of the product's unique benefits so that more chronic pain sufferers can experience relief."

About Quell Wearable Pain Relief Device

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's wearable intensive nerve stimulation (WINS) technology to provide pain relief. In a recent clinical study, Quell improved chronic pain and overall health in 81% of participants. Quell is currently available through select healthcare professionals, retailers and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150922005321/en/

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media